21.45
+0.05%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dian Diagnostics Group Co
Its shares trade on Shenzhen under the ticker 300244.SZ. It has been listed since 19 July 2011. In the fiscal year to 31 December 2025, it reported revenue of CN¥10.10bn and net income of CN¥44.1m. At that date it held total assets of CN¥14.42bn and shareholders' equity of CN¥6.44bn.
Dian Diagnostics Group Co. Ltd. engages in the sale, outsourcing, research and development of medical diagnostic product and services. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2011-07-19. The firm's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The firm's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The firm's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 19 Jul 2011
- Employees
- 11,123
- Website
- dazd.cn ↗
Leadership
Pay as last reported
- Mr. Haibin ChenChairman of the Board, General Manager, since 2010CN¥3.0m
- Mr. Dekang ZhaoFinance Director, Deputy General Manager, Director, since 2023CN¥2.8m
- Ms. Jun TaoDeputy General Manager, Secretary of the BoardCN¥985,900
- Mr. Sanhui GuoDeputy General Manager, Director, since 2019CN¥2.6m
- Mr. Weiyan WuDeputy General ManagerCN¥2.1m
- Mr. Xiaoping YeDirector
- Mr. Dechao YuDirector
- Mr. Zelin DengIndependent Director
- Mr. Bin JiangIndependent DirectorCN¥120,000
- Mr. Tiantian LiIndependent DirectorCN¥120,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 77
- Environment
- 99
- Social
- 99
- Governance
- 34
- Direct emissions (scope 1)
- 284.31 t
- Energy emissions (scope 2)
- 15,600.04 t
- Women in the workforce
- 56.49151%
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dian Diagnostics Group Co Ltd possesses several key strengths that contribute to its success in the market. These include:
Weaknesses
- Despite its strengths, Dian Diagnostics Group Co Ltd also faces certain weaknesses that need to be addressed for further growth:
Opportunities
- Dian Diagnostics Group Co Ltd can capitalize on the following opportunities to enhance its position in the market:
Threats
- Dian Diagnostics Group Co Ltd should be aware of the following potential threats that may impact its performance:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.